Correction: Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study

Autor: Jean Olivier Twahirwa Rwema, Vianney Nizeyimana, Neia M. Prata, Nneoma E. Okonkwo, Amelia A. Mazzei, Sulemani Muhirwa, Athanase Rukundo, Lisa Lucas, Audace Niyigena, Jean Damascene Makuza, Chris Beyrer, Stefan D. Baral, Aflodis Kagaba

Publikováno v: Harm Reduction Journal, Vol 19, Iss 1, Pp 1-3 (2022)

Externí odkaz: https://doaj.org/article/721b1a0adaa443efa9466c04d24b96b0

Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign.

Autor: Nyombayire J; Center for Family Health Research, Kigali, Rwanda., Ingabire R; Center for Family Health Research, Kigali, Rwanda., Magod B; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA., Mazzei A; Center for Family Health Research, Kigali, Rwanda.; Department of Pathology, School of Medicine, Emory University, Atlanta, Georgia, USA., Mazarati JB; Rwanda Biomedical Center, Kigali, Rwanda., Noben J; Janssen Global Public Health R&D, Beerse, Belgium., Katwere M; Janssen Vaccines and Prevention, Leiden, The Netherlands., Parker R; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA., Nsanzimana S; Rwanda Biomedical Center, Kigali, Rwanda., Wall KM; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., Sayinzoga F; Rwanda Biomedical Center, Kigali, Rwanda., Tichacek A; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA., Robinson C; Janssen Vaccines and Prevention, Leiden, The Netherlands., Hammoud N; Janssen Vaccines and Prevention, Leiden, The Netherlands., Priddy F; Independent Consultant, Wellington, New Zealand., Allen S; Rwanda Zambia Health Research Group, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA., Karita E; Department of Pathology, School of Medicine, Emory University, Atlanta, Georgia, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2023 Jan 11; Vol. 227 (2), pp. 268-277.

Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial.

Autor: Karita E; Rwanda Zambia Health Research Group, Center for Family Health Research/Projet San Francisco, Kigali, Rwanda., Nyombayire J; Rwanda Zambia Health Research Group, Center for Family Health Research/Projet San Francisco, Kigali, Rwanda., Ingabire R; Rwanda Zambia Health Research Group, Center for Family Health Research/Projet San Francisco, Kigali, Rwanda., Mazzei A; Rwanda Zambia Health Research Group, Center for Family Health Research/Projet San Francisco, Kigali, Rwanda., Sharkey T; Rwanda Zambia Health Research Group, Center for Family Health Research/Projet San Francisco, Kigali, Rwanda., Mukamuyango J; Rwanda Zambia Health Research Group, Center for Family Health Research/Projet San Francisco, Kigali, Rwanda., Allen S; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Tichacek A; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Parker R; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Priddy F; Madison, USA., Sayinzoga F; Rwanda Biomedical Center, Kigali, Rwanda., Nsanzimana S; Rwanda Biomedical Center, Kigali, Rwanda., Robinson C; Janssen Vaccines and Prevention, Leiden, the Netherlands., Katwere M; Janssen Vaccines and Prevention, Leiden, the Netherlands., Anumendem D; Janssen Vaccines and Prevention, Leiden, the Netherlands., Leyssen M; Janssen Vaccines and Prevention, Leiden, the Netherlands., Schaefer M; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Maternal Fetal Medicine, University of Pittsburgh Magee-Women's Hospital, Pittsburgh, PA, USA., Wall KM; Rwanda Zambia Health Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA. kmwall@emory.edu.; Department of Epidemiology, Rollins School of Public Health, Laney Graduate School, Emory University, Atlanta, GA, USA. kmwall@emory.edu.

Publikováno v: Trials [Trials] 2022 Jun 20; Vol. 23 (1), pp. 513. Date of Electronic Publication: 2022 Jun 20.

Antibiotic-resistant Neisseria gonorrhoeae and changes to the 2019 Rwandan National STI Guidelines.

Autor: Wall KM; Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health and Department of Epidemiology, Rollins School of Public Health, Laney Graduate School, 1371Emory University, Atlanta, GA, USA., Nyombayire J; Projet San Francisco, Rwanda Zambia HIV Research Group, Kigali, Rwanda., Parker R; Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health, Rollins School of Public Health, Laney Graduate School, 1371Emory University, Atlanta, GA, USA., Ingabire R; Projet San Francisco, Rwanda Zambia HIV Research Group, Kigali, Rwanda., Bizimana J; Projet San Francisco, Rwanda Zambia HIV Research Group, Kigali, Rwanda., Mukamuyango J; Projet San Francisco, Rwanda Zambia HIV Research Group, Kigali, Rwanda., Mazzei A; Projet San Francisco, Rwanda Zambia HIV Research Group, Kigali, Rwanda., Price MA; IAVI, NY, NY, University of California San Francisco, San Francisco, CA, USA., Unyuzimana MA; Projet San Francisco, Rwanda Zambia HIV Research Group, Kigali, Rwanda., Tichacek A; Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health, Rollins School of Public Health, Laney Graduate School, 1371Emory University, Atlanta, GA, USA., Allen S; Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health, Rollins School of Public Health, Laney Graduate School, 1371Emory University, Atlanta, GA, USA., Karita E; Projet San Francisco, Rwanda Zambia HIV Research Group, Kigali, Rwanda.

Publikováno v: International journal of STD & AIDS [Int J STD AIDS] 2022 Mar; Vol. 33 (3), pp. 315-317. Date of Electronic Publication: 2021 Dec 08.

Leapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in Rwanda.

Autor: Mc Kenna P; Johnson & Johnson Global Public Health, Janssen Pharmaceutica N.V., Beerse, Belgium., Masyn S; Johnson & Johnson Global Public Health, Janssen Pharmaceutica N.V., Beerse, Belgium., Willems A; Johnson & Johnson Global Public Health, Janssen Pharmaceutica N.V., Beerse, Belgium., De Paepe A; Johnson & Johnson Global Public Health, Janssen Pharmaceutica N.V., Beerse, Belgium., Rutten R; Johnson & Johnson Global Public Health, Janssen Pharmaceutica N.V., Beerse, Belgium., Mazarati JB; Department of Biomedical Services, Rwanda Biomedical Centre, Kigali, Rwanda., Sayinzoga F; Maternal, Child and Community Health Division, Rwanda Biomedical Center, Kigali, Rwanda., Karita E; Project San Francisco/Center for Family Health Research, Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Kigali, Rwanda., Nduwamungu JN; Project San Francisco/Center for Family Health Research, Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Kigali, Rwanda., Mazzei A; Project San Francisco/Center for Family Health Research, Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Kigali, Rwanda., Nyombayire J; Project San Francisco/Center for Family Health Research, Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Kigali, Rwanda., Ingabire R; Project San Francisco/Center for Family Health Research, Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Kigali, Rwanda., Amponsah M; Grameen Foundation, Washington, DC, USA., Egoeh SG; Grameen Foundation, Washington, DC, USA., Ezeanochie N; Johnson and Johnson Health and Wellness Solutions, Inc., New Brunswick, NJ, USA.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Sep 02; Vol. 17 (9), pp. 3192-3202. Date of Electronic Publication: 2021 Jun 02.